Submitted by reuters8361 in news
Shares of dialysis service providers fell sharply on Wednesday after Novo Nordisk's <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> Ozempic showed early signs of success in delaying the progression of kidney disease…